Abstract
Background: For patients with drug-refractory atrial fibrillation, radiofrequency catheter ablation of the atrioventricular junction and pacemaker implantation is a nonpharmacologic option routinely used nowadays. Few data are available on the long-term survival following the procedure or on evaluation of the risk factors for death in a large study cohort.
Methods: The patient population included 359 subjects undergoing atrioventricular junction ablation and pacemaker insertion. Fourteen clinical and 9 ablation variables were collected at baseline. During a mean following-up of 40.8±25.6 months, 46 patients died. Survival probability was estimated by the Kaplan-Meier methods. Multivariate Cox proportional hazards regression analysis was applied to define predictors of death.
Results: Mean age was 64.6±10.6 years with 203 male (57.7%). Actuarial survival probability for the total patients was 0.953 and 0.827 at 1 and 5 year. Four clinical variables, but no ablation variables, were found to be independent predictors of death: age ≥65 year (hazard ratio [HR], 1.92; 95% confidence interval [CI], 1.00–3.69), the presence of heart failure (HR, 3.83; 95% CI, 1.87–7.86), coexisting diabetes (HR, 2.91; 95% CI, 1.47–5.77), and the value of fractional shortening ≤20% (HR, 5.79, 95% CI, 3.00–11.18). There were 20 deaths in 28 patients with ≥3 risk factors and 4 deaths in 115 patients with no risk factor.
Conclusion: The risk of death in patients undergoing ablation and pacing can be identified by readily available clinical variables. Patients with multiple risk factors are associated with an increasing mortality.
Similar content being viewed by others
References
Falk RH. Atrial fibrillation. In: Podrid PJ, Kowey PR, eds. Cardiac arrhythmia: mechanisms, diagnosis and management. Baltimore: Williams & Wilkins, 1995; 803–827.
Hohnloser SH, Van de Loo A, Baedeker F. Efficacy and proarrhythmic hazards of Pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine. J AmColl Cardiol 1995; 26: 852–858.
Chun SH, Sager PT, Stevenson WG, Nademanee K, Middlekauff HR, Singh BN. Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter.Am J Cardiol 1995; 76: 47–50.
Touboul P. Atrioventricular nodal ablation and pacemaker implantation in patients with atrial fibrillation. Am J Cardiol 1999; 83: 241D–245D.
Langberg JJ, Chin MC, Rosenqvist M, Cockrell J, Dullet N, Van Hare G, Griffin JC, Scheinman MM. Catheter ablation of the atrioventricular junction with radiofrequency energy. Circulation 1989; 80: 1527–1535.
Yeung-Lai-Wah JA, Alison JF, Lonergan L, Mohama R, Leather R, Kerr CR. High success rate of atrioventric ular node ablation with radiofrequency energy. J Am Coll Cardiol 1991; 18: 1753–1758.
Kay GN, Epstein AE, Dailey SM, Plumb VJ. Role of radiofrequency ablation in the management of supraventricular arrhythmias: experience in 760 consecutive patients. J Cardiovasc Electrophysiol 1993; 4: 371–389.
Sousa J, el-Atassi R, Rosenheck S, Calkins H, Langberg J, Morady F. Radiofrequency catheter ablation of the atrioventricular junction from the left ventricule. Circulation 1991; 84: 567–571.
Kay GN, Ellenbogen KA, Giudici M, Redfield MM, Jenkins LS, Mianulli M, Wilkoff B. The ablate and pace trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. J Interv Card Electrophysiol 1998; 2: 121–135.
Brignole M, Gianfranchi L, Menozzi C, Bottoni N, Bollini R, Lolli G, Oddone F, Gaggioli G. Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol 1994; 74: 242–246.
Fitzpatrick AP, Kourouyan HD, Siu A, Lee RJ, Lesh MD, Epstein LM, Griffin JC, Scheinman MM. Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation. Am Heart J 1996; 131: 499–507.
Heinz G, Siostrzonek P, Kreiner G, Gossinger H. Improvement in left ventricular systolic function after successful radiofrequency His bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol 1992; 69: 489–492.
Bubien RS, Knotts-Dolson SM, Plumb VJ, Kay GN. Effect of radiofrequency catheter ablation on healthrelated quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation 1996; 94: 1585–1591.
Lee SH, Chen SA, Tai CT, Chiang CE, Wen ZC, Cheng JJ, Ding YA, Chang MS. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol 1998; 31: 637–644.
Ozcan C, Jahangir A, Friedman PA, Patel PJ, Munger TM, Rea RF, Lloyd MA, Packer DL, Hodge DO, Gersh BJ, Hammill SC, Shen WK. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 2001; 344: 1043–1051.
Jensen SM, Bergfeldt L, Rosenqvist M. Long-term follow-up of patients treated by radiofrequency ablation of atrioventricular junction. PACE 1995; 18: 1609–1614.
Ozin B, Mackall G, Van Hare G, Carlson M, Rosenbaum D, Waldo AL, Biblo L. A case control study of mortality after radiofrequency ablation of the AV junction. J Am Coll Cardiol 1997; 29: 199A–200A.
Alison JF, Yeung-Lai-Wah JA, Schulzer M, Kerr CR. Characterization of junctional rhythm after atrioventricular node ablation. Circulation 1995; 91: 84–90.
Calkins H, Yong P, Miller JM, Olshansky B, Carlson M, Saul JP, Huang SKS, Liem B, Klein LS, Moser SA, Bloch DA, Gillette P, Prystowsky E, for the Atakr Multicenter Investigators Group. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective multicenter trial. Circulation 1999; 99: 262–270.
Twidale N, Manda V, Holliday R, Boler S, Sparks L, Crain J, Carrier S. Mitral regurgitation after atrioventricular node catheter ablation for atrial fibrillation and heart failure: acute hemodynamic features. Am Heart J 1999; 138: 1166–1175.
Melton IC, Wood MA, Ellenbogen KA. Radiofrequency atrioventricular junction ablation for atrial fibrillation: how can we make it better? AmHeart J 1999; 138: 1016–1018.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yeung-Lai-Wah, J.A., Qi, A., Uzun, O. et al. Long-Term Survival Following Radiofrequency Catheter Ablation of Atrioventricular Junction for Atrial Fibrillation: Clinical and Ablation Determinants of Mortality. J Interv Card Electrophysiol 6, 17–23 (2002). https://doi.org/10.1023/A:1014168021615
Issue Date:
DOI: https://doi.org/10.1023/A:1014168021615